P S Mahal - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

P S Mahal

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Diseases of the Colon and Rectum|September 1, 1983

Epithelioid leiomyosarcoma (malignant leiomyoblastoma) of the colonM Y Khan, E J Schweitzer, P S Mahal

European Journal of Cancer & Clinical Oncology|December 1, 1981

AMSA toxicity in patients with abnormal liver functionP S Mahal, S S Legha, M Valdivieso, et al.

Cancer Treatment Reports|August 1, 1982

Phase I--II study of the combination of 5-FU, doxorubicin, mitomycin, and semustine (FAMMe) in the treatment of adenocarcinoma of the stomach, gastroesophageal junction, and pancreasD A Karlin, J R Stroehlein, R W Bennetts, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Diseases of the Colon and Rectum|September 1, 1983

Epithelioid leiomyosarcoma (malignant leiomyoblastoma) of the colonM Y Khan, E J Schweitzer, P S Mahal

European Journal of Cancer & Clinical Oncology|December 1, 1981

AMSA toxicity in patients with abnormal liver functionP S Mahal, S S Legha, M Valdivieso, et al.

Cancer Treatment Reports|August 1, 1982

Phase I--II study of the combination of 5-FU, doxorubicin, mitomycin, and semustine (FAMMe) in the treatment of adenocarcinoma of the stomach, gastroesophageal junction, and pancreasD A Karlin, J R Stroehlein, R W Bennetts, et al.

Pageof 1